- Home
- TAL vs RGEN Comparison
TAL vs RGEN Comparison
Compare TAL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAL
- RGEN
- Stock Information
- Founded
- TAL 2003
- RGEN 1981
- Country
- TAL China
- RGEN United States
- Employees
- TAL N/A
- RGEN N/A
- Industry
- TAL Other Consumer Services
- RGEN Medical/Dental Instruments
- Sector
- TAL Real Estate
- RGEN Health Care
- Exchange
- TAL Nasdaq
- RGEN Nasdaq
- Market Cap
- TAL 6.4B
- RGEN 6.5B
- IPO Year
- TAL 2010
- RGEN N/A
- Fundamental
- Price
- TAL $11.00
- RGEN $113.74
- Analyst Decision
- TAL Buy
- RGEN Buy
- Analyst Count
- TAL 4
- RGEN 10
- Target Price
- TAL $12.66
- RGEN $163.78
- AVG Volume (30 Days)
- TAL 3.8M
- RGEN 671.7K
- Earning Date
- TAL 10-23-2025
- RGEN 11-11-2025
- Dividend Yield
- TAL N/A
- RGEN N/A
- EPS Growth
- TAL 91.79
- RGEN N/A
- EPS
- TAL 0.17
- RGEN N/A
- Revenue
- TAL $2,411,045,000.00
- RGEN $673,956,000.00
- Revenue This Year
- TAL $32.96
- RGEN $16.74
- Revenue Next Year
- TAL $23.43
- RGEN $13.86
- P/E Ratio
- TAL $65.76
- RGEN N/A
- Revenue Growth
- TAL 47.99
- RGEN 8.73
- 52 Week Low
- TAL $7.35
- RGEN $102.97
- 52 Week High
- TAL $15.30
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- TAL 56.19
- RGEN 41.21
- Support Level
- TAL $10.35
- RGEN $117.18
- Resistance Level
- TAL $10.62
- RGEN $122.71
- Average True Range (ATR)
- TAL 0.28
- RGEN 4.25
- MACD
- TAL 0.03
- RGEN -0.76
- Stochastic Oscillator
- TAL 87.68
- RGEN 8.17
About TAL TAL Education Group
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.